Jeremy Joseph
SPARK Advisor at Stanford University School of Medicine
San Francisco, California
Overview
Work Experience
SPARK Advisor
2019 - Current
Adviser to Stanford's center for translational research, helping create the next generation of therapeutics.
Biotech/Agtech VC Investor
2019
Data Collective (DCVC) is the first venture capital firm in Silicon Valley to invest exclusively in entrepreneurs building companies based on Big Data and deep compute. Advances in genetic sequencing, artificial intelligence and automation are converging to transform existing life sciences technologies and speed the development of new ones. We are looking for companies affecting deep technological change in synthetic biology, medicine, and agriculture. We have invested in Frontier Medicines (Drug Discovery & Chemoproteomics), Abcellera (Next-Gen Antibodies), GenEdit (Gene Therapy Delivery), Pivot Bio (Agriculture), Blue River (Agriculture robots), Atomwise (Drug Discovery & AI) and more... https://www.dcvc.com
DCVC backs entrepreneurs using deep tech to solve problems and multiply the benefits of capitalism for everyone while reducing its cost.
Member
2019
Sloan Fellow at Stanford Graduate School of Business, MS in Business & Management
2018 - 2019
DCVC Bio Venture Scholar Co-Lead Stanford Impact Investment Fund GSB Student-Alumni Committee Liaison Cardinal Pitch Club Scout Independent Study with Professor Sarah Soule
Strategy Manager
2015 - 2018
Stanford Graduate School of Business - Executive Leadership Program (2017) Above & Beyond Winner - (2016) Finalist for CBO ACE Awards 2017 - Empowered Partnership Nominated for ACE Awards (2016 & 2017)- Nominated for Marketing Excellence Award (2017) - Alecensa Nominated for F&BAer of the Quarter (1Q16)
Genentech specializes in genetic testing and personalized medicine.
Healthcare Venture Capital Investor in Digital Health, Medical Devices & Life Sciences
2014 - 2015
Deal Teams: Evidation Health: GE Ventures’ first healthcare NewCo RainDance Technologies: $18.5M Series E Chrono Therapeutics: $32M Series A Talks StartOut (GE Ventures), Biotech – The Other Silicon Valley Tech (Panelist, 2014) Energizing Health Houston (GE Ventures), Texas Medical Accelerator Center Launch (Panelist, 2014)
GE Healthcare provides a wide range of medical technologies and services to healthcare providers and researchers.
Raised $5,524,660,836.00 from Bill & Melinda Gates Foundation.
Senior Associate (U.S. Pharmaceuticals Equity Research/Investment Banking)
2012 - 2014
Nominated for Above & Beyond Associate by Sales & Trading (June 2013) and featured on Credit Suisse Alumni Website for professional excellence (August 2012) Selected for Top 10 Thought Pieces of 2012 in Equity Research Department - “Deep Dive into Genomic Medicine” Developed research reports that provided investment insights on biotech drugs and life sciences tools for investment
Credit Suisse Group is a financial services company that advises clients in all aspects of finance.
Associate
2011 - 2012
Lazard is a financial advisory and asset management firm focused on income strategies, alternative investments, and private equity funds.
Raised $400,000,000.00.
Associate GCM
2010 - 2011
Morgan Stanley Venture Partners is a private equity firm that invests in high-growth companies in the technology and healthcare industries.
Fellow
2008 - 2009